Competitive Technologies, Inc. (NYSE Amex: CTT) announced that its Calmare® Therapy Treatment medical device has been commercially launched in Rhode Island.
Company has its eye on the EUR 2+ billion cardiac arrhythmia ablation market
But they warn the procedure could be hard to replicate.
Will offer MR pulse sequencing capabilities
SIERRA's expert panel proposes its first recommendations on patient care, radiation reduction.
Company to contribute data to industry-sponsored Dual Antiplatelet Therapy (DAPT) Study.
Significant benefit of hyperbaric oxygen therapy to improve brain metabolism and its ability to recover from injury.
Combining to offer a more robust portfolio to healthcare providers
Cone beam technology is driving the industry
Curcumin, the major component in the spice turmeric, when combined with the drug Cisplatin enhances the chemotherapy's suppression of head and neck cancer cell growth, researchers with UCLA's Jonsson Cancer Center have found.
May ultimately help reduce need for invasive biopsies
Former Hill-Rom executive joins Seno Medical Instruments as VP of Quality Assurance and Regulatory Affairs
Can they co-exist and thrive in the Age of Accelerations?
The danger of false expectations and 'the next big thing'
Lack of direct communication may contribute significantly to patient misinformation
New insights from the 11,000 patient IDEAS study
Software patch should resolve issue, recall not expected
